Alzheimer's Disease, Cold Spring Harbor Perspectives in Biology, vol.3, issue.7, pp.741-66, 2001. ,
DOI : 10.1101/cshperspect.a004457
Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in pharmacological sciences, pp.383-391, 1991. ,
An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque Depositions, Experimental Neurobiology, vol.22, issue.2, pp.84-95, 2013. ,
DOI : 10.5607/en.2013.22.2.84
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles, Neuron, vol.39, issue.3, pp.409-430, 2003. ,
DOI : 10.1016/S0896-6273(03)00434-3
A mutation in APP protects against Alzheimer???s disease and age-related cognitive decline, Nature, vol.43, issue.7409, pp.96-910, 1038. ,
DOI : 10.1038/ng.781
Acute function of secreted amyloid precursor protein fragment APPsalpha in synaptic plasticity, Acta neuropathologica, vol.129, issue.1, 2015. ,
Intraventricular infusions of antibodies to amyloid-??-protein precursor impair the acquisition of a passive avoidance response in the rat, Neuroscience Letters, vol.115, issue.1, pp.97-102, 1990. ,
DOI : 10.1016/0304-3940(90)90524-D
Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach, Brain Research, vol.603, issue.2, pp.348-52, 1993. ,
DOI : 10.1016/0006-8993(93)91261-P
Comparative analysis of single and combined APP/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPs?? expression, Acta Neuropathologica Communications, vol.460, issue.1, pp.36-46, 2014. ,
DOI : 10.1016/j.neulet.2009.05.040
Correlative Memory Deficits, A?? Elevation, and Amyloid Plaques in Transgenic Mice, Science, vol.2, issue.8, pp.99-102, 1996. ,
DOI : 10.1038/nm0896-864
Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein., Proceedings of the National Academy of Sciences, vol.92, issue.12, pp.5341-5346, 1995. ,
DOI : 10.1073/pnas.92.12.5341
Single App knock-in mouse models of Alzheimer's disease, Nature Neuroscience, vol.97, issue.5, pp.661-664, 2014. ,
DOI : 10.1073/pnas.97.26.14731
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics, Nature Reviews Drug Discovery, vol.16, issue.9, pp.698-712, 2011. ,
DOI : 10.1111/j.1750-3639.2006.tb00559.x
Formation of ??-amyloid protein deposits in brains of transgenic mice, Nature, vol.352, issue.6332, pp.239-4110, 1038. ,
DOI : 10.1038/352239a0
Transgenic Mice Expressing Human ??-APP751, But Not Mice Expressing ??-APP695, Display Early Alzheimer's Disease-like Histopathologya, Annals of the New York Academy of Sciences, vol.352, issue.1, pp.224-231, 1993. ,
DOI : 10.1038/352239a0
Cellular mechanisms of beta -amyloid production and secretion, Proceedings of the National Academy of Sciences, vol.23, issue.2, pp.11049-53, 1999. ,
DOI : 10.1016/S0169-328X(97)00091-0
Presenilin 1 Mutations Linked to Familial Alzheimer's Disease Increase the Intracellular Levels of Amyloid ??-Protein 1-42 and Its N-Terminally Truncated Variant(s) Which Are Generated at Distinct Sites, Journal of Neurochemistry, vol.71, issue.4, pp.1535-1578, 1998. ,
DOI : 10.1046/j.1471-4159.1998.71041535.x
Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin, Proceedings of the National Academy of Sciences, vol.450, issue.1, pp.8733-8741, 1999. ,
DOI : 10.1113/jphysiol.1992.sp019148
Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus. The Journal of physiology, pp.373-83, 2007. ,
Encoding and storage of spatial information in the retrosplenial cortex, Proceedings of the National Academy of Sciences, vol.16, issue.5, pp.8661-8667, 2014. ,
DOI : 10.1038/nn.3311
Mapping fear memory consolidation and extinction-specific expression of JunB. Neurobiology of learning and memory, 2015. ,
DOI : 10.1016/j.nlm.2015.08.007
Neuronal Circuits for Fear Expression and Recovery: Recent Advances and Potential Therapeutic Strategies, Biological Psychiatry, vol.78, issue.5, pp.298-306, 2015. ,
DOI : 10.1016/j.biopsych.2015.03.017
NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss, Cell Death and Disease, vol.18, issue.4, 2013. ,
DOI : 10.1242/jcs.048090
URL : http://doi.org/10.1038/cddis.2013.129
Hyperphosphorylation of Tau induced by naturally secreted amyloid-beta at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3beta signaling pathway. The Journal of biological chemistry, pp.35222-35255, 2012. ,
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease, Acta Neuropathologica, vol.103, issue.1, pp.26-3510, 2001. ,
DOI : 10.1007/s004010100423
Roles of the amyloid precursor protein family in the peripheral nervous system. Mechanisms of development, pp.6-8433, 2013. ,
Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging, Experimental Brain Research, vol.81, issue.3-4, pp.3-4471, 2012. ,
DOI : 10.1016/0092-8674(95)90073-X
Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1??E9-deleted transgenic mice model of ??-amyloidosis, Neurobiology of Aging, vol.31, issue.7 ,
DOI : 10.1016/j.neurobiolaging.2008.08.005
Repair of Rhodopsin mRNA by Spliceosome-Mediated RNA Trans-Splicing: A New Approach for Autosomal Dominant Retinitis Pigmentosa. Molecular therapy : the journal of the American Society of Gene Therapy ,
The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events, Journal of Neuroscience Methods, vol.108, issue.1, pp.71-83, 2001. ,
DOI : 10.1016/S0165-0270(01)00374-0
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy, Science, vol.116, issue.11, pp.818-82310, 2009. ,
DOI : 10.1172/JCI28873
Viral vectors as tools to model and treat neurodegenerative disorders. The journal of gene medicine, pp.530-53910, 2005. ,
Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice, PloS one, vol.5, 2010. ,
Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum, PLoS ONE, vol.24, issue.3, 2013. ,
DOI : 10.1371/journal.pone.0059166.t002
AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice, PLoS ONE, vol.48, issue.10, 2009. ,
DOI : 10.1371/journal.pone.0007280.s010
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis, Science, vol.300, issue.5618, pp.486-48910, 2003. ,
DOI : 10.1126/science.1079469
Analysis of differential plaque depositions in the brains of Tg2576 and ,
PS1dE9 transgenic mouse models of Alzheimer's disease. Experimental & molecular medicine 44, pp.492-502, 2012. ,
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.22, pp.2780-279120026246, 2002. ,
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels, Molecular neurodegeneration, vol.2, issue.11, pp.10-1186, 2007. ,
DOI : 10.1186/1750-1326-2-11
URL : http://doi.org/10.1186/1750-1326-2-11
An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque Depositions, Experimental Neurobiology, vol.22, issue.2, pp.84-95, 2013. ,
DOI : 10.5607/en.2013.22.2.84
Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein, Neurobiology of Disease, vol.22, issue.1, pp.10-24011, 2006. ,
DOI : 10.1016/j.nbd.2005.09.011
Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP, Science, vol.293, issue.5534, pp.1487-149110, 2001. ,
DOI : 10.1126/science.1058189
??-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease, Proceedings of the National Academy of Sciences, vol.95, issue.1, pp.10813-1081810, 2002. ,
DOI : 10.1016/S0092-8674(00)81782-1
Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein, Nature, vol.387, issue.6632, pp.500-50510, 1997. ,
DOI : 10.1038/387500a0
A??42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice, Neuron, vol.47, issue.2, pp.191-199030, 2005. ,
DOI : 10.1016/j.neuron.2005.06.030
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease, Neurobiology of Aging, vol.24, issue.8, pp.1063-1070, 2003. ,
DOI : 10.1016/j.neurobiolaging.2003.08.012
Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits, Proceedings of the National Academy of Sciences, vol.26, issue.2, pp.9572-957710, 2003. ,
DOI : 10.1016/S0893-133X(01)00332-3
Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits, The American Journal of Pathology, vol.169, issue.2, pp.599-616060002, 2006. ,
DOI : 10.2353/ajpath.2006.060002
Presenilin, Notch, and the genesis and treatment of Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.48, issue.4, pp.11039-11041211352598, 2001. ,
DOI : 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.0.CO;2-W
Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.22, pp.133-141, 2002. ,
Impaired Eyeblink Conditioning and Decreased Hippocampal Volume in PDAPP V717F Mice, Neurobiology of Disease, vol.11, issue.3, pp.425-433, 2002. ,
DOI : 10.1006/nbdi.2002.0555
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.22, pp.1858-1867, 2002. ,
Cognitive and Physical Activity Differently Modulate Disease Progression in the Amyloid Precursor Protein (APP)-23 Model of Alzheimer???s Disease, Biological Psychiatry, vol.60, issue.12, pp.1314-1323, 2006. ,
DOI : 10.1016/j.biopsych.2006.04.004
Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimer's research & therapy 6, p.37, 2014. ,
DOI : 10.1186/alzrt269
URL : http://alzres.biomedcentral.com/track/pdf/10.1186/alzrt269?site=alzres.biomedcentral.com
Dementia in western Europe: epidemiological evidence and implications for policy making, The Lancet Neurology, vol.15, issue.1, pp.116-124, 2016. ,
DOI : 10.1016/S1474-4422(15)00092-7
Über einen eigenartigen schweren Erkrankung-sproze? der Hirnrinde, Neurologisches Centralblatt, vol.23, pp.1129-1136, 1906. ,
An English translation of Alzheimer's 1907 paper, Uber eine eigenartige Erkankung der Hirnrinde, pp.429-431, 1995. ,
Auguste D and Alzheimer's disease, The Lancet, vol.349, issue.9064, pp.1546-1549, 1997. ,
DOI : 10.1016/S0140-6736(96)10203-8
Uber klinisch und histologisch eigenartige psychische Erkrankungen des späteren Lebensalters, Histologische und Histopathologische Arbeiten, pp.297-351, 1909. ,
Über eigenartige Krankheitsfälle des späteren Alters. Zeitschrift für die gesamte neurologie und psychiatrie 4, pp.356-385, 1911. ,
DOI : 10.1177/0957154x9100200506
Alzheimer's second patient: Johann F. and his family, Annals of Neurology, vol.5, issue.suppl 3, pp.520-523, 2002. ,
DOI : 10.1093/hmg/5.7.985
Sur les proprietes optiques de l'amyloide, C R Soc Biol, vol.97, pp.1808-1810, 1927. ,
Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease, Nature, vol.86, issue.4863, pp.192-193, 1963. ,
DOI : 10.1113/jphysiol.1961.sp006744
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochemical and Biophysical Research Communications, vol.120, issue.3, pp.885-890, 1984. ,
DOI : 10.1016/S0006-291X(84)80190-4
The Nature and Pathogenesis of the Amyloid Deposits in Alzheimer???s Disease, Appl Pathol, vol.2, pp.357-369, 1984. ,
DOI : 10.1007/978-94-009-4309-4_24
One of the Antigenic Determinants of Paired Helical Filaments Is Related to Tau Protein1, The Journal of Biochemistry, vol.99, issue.5, pp.1541-1544, 1986. ,
DOI : 10.1093/oxfordjournals.jbchem.a135625
Microtubuleassociated protein tau. A component of Alzheimer paired helical filaments, The Journal of biological chemistry, vol.261, pp.6084-6089, 1986. ,
Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides., Proceedings of the National Academy of Sciences, vol.84, issue.12, pp.4190-4194, 1987. ,
DOI : 10.1073/pnas.84.12.4190
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease, Science, vol.254, issue.5028, pp.97-99, 1991. ,
DOI : 10.1126/science.1925564
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, vol.349, issue.6311, pp.704-706, 1991. ,
DOI : 10.1038/349704a0
Early-onset Alzheimer's disease caused by mutations at codon 717 of the ??-amyloid precursor protein gene, Nature, vol.353, issue.6347, pp.844-846, 1991. ,
DOI : 10.1038/353844a0
A locus for familial early???onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the ??1???antichymotrypsin gene, Nature Genetics, vol.47, issue.4, pp.340-342, 1992. ,
DOI : 10.1016/0022-3956(75)90026-6
Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, issue.5054, pp.184-185, 1992. ,
DOI : 10.1126/science.1566067
A novel mutation of presenilin 1 in familial Alzheimer's disease in Israel detected by denaturing gradient gel electrophoresis, Human Genetics, vol.98, issue.6, pp.700-702, 1996. ,
DOI : 10.1007/s004390050288
The E280A presenilin 1 Alzheimer mutation produces increased A??42 deposition and severe cerebellar pathology, Nature Medicine, vol.1, issue.10, pp.1146-1150, 1996. ,
DOI : 10.1038/360672a0
Beta-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE, Science, vol.286, issue.5440, pp.735-741, 1999. ,
DOI : 10.1126/science.286.5440.735
Brain Changes in Older Adults at Very Low Risk for Alzheimer's Disease, Journal of Neuroscience, vol.33, issue.19, pp.8237-8242, 2013. ,
DOI : 10.1523/JNEUROSCI.5506-12.2013
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050197
Neuropathologic Basis of Age-Associated Brain Atrophy, JAMA Neurology, vol.70, issue.5, pp.616-622, 2013. ,
DOI : 10.1001/jamaneurol.2013.1957
Phases of A??-deposition in the human brain and its relevance for the development of AD, Neurology, vol.58, issue.12, pp.1791-1800, 2002. ,
DOI : 10.1212/WNL.58.12.1791
Brain Oligomeric ??-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice, Journal of Neuropathology & Experimental Neurology, vol.70, issue.5, pp.360-376, 2011. ,
DOI : 10.1097/NEN.0b013e318217a118
Accelerating Amyloid-?? Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models, Journal of Biological Chemistry, vol.157, issue.33, pp.23818-23828, 2007. ,
DOI : 10.1016/S0896-6273(03)00850-X
A new amyloid ?? variant favoring oligomerization in Alzheimer's-type dementia, Annals of Neurology, vol.61, issue.3, pp.377-387, 2008. ,
DOI : 10.1002/ana.21321
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition, Archives of neurology, vol.66, pp.1476-1481, 2009. ,
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease, Archives of Neurology, vol.66, issue.12, pp.1469-1475, 2009. ,
DOI : 10.1001/archneurol.2009.269
FORM AND DISTRIBUTION OF SENILE PLAQUES SEEN IN SILVER IMPREGNATED SECTIONS IN THE BRAINS OF INTELLECTUALLY NORMAL ELDERLY PEOPLE AND PEOPLE WITH ALZHEIMER-TYPE DEMENTIA, Neuropathology and Applied Neurobiology, vol.3, issue.5, pp.379-389, 1983. ,
DOI : 10.1016/0022-510X(82)90155-1
Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques, Neurology, vol.46, issue.2, pp.425-429, 1996. ,
DOI : 10.1212/WNL.46.2.425
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology, vol.42, issue.3, pp.631-639, 1992. ,
DOI : 10.1212/WNL.42.3.631
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease, Neurology, vol.60, issue.9, pp.1495-1500, 2003. ,
DOI : 10.1212/01.WNL.0000063311.58879.01
ALZHEIMER???S DISEASE ???AN ELECTRON MICROSCOPICAL STUDY, Brain, vol.87, issue.2, pp.307-320, 1964. ,
DOI : 10.1093/brain/87.2.307
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology., Proceedings of the National Academy of Sciences, vol.83, issue.13, pp.4913-4917, 1986. ,
DOI : 10.1073/pnas.83.13.4913
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease, Acta Neuropathologica, vol.103, issue.1, pp.26-35, 2002. ,
DOI : 10.1007/s004010100423
Neuropathological stageing of Alzheimer-related changes, Acta Neuropathologica, vol.80, issue.4, pp.239-259, 1991. ,
DOI : 10.1007/978-3-642-70644-8_2
Anatomic localization of the transentorhinal region of the perirhinal cortex, Neurobiology of Aging, vol.29, issue.10, pp.1591-1596, 2008. ,
DOI : 10.1016/j.neurobiolaging.2007.03.024
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease, Neurobiology of Aging, vol.12, issue.4, pp.295-312, 1991. ,
DOI : 10.1016/0197-4580(91)90006-6
Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease, Acta Neuropathologica, vol.95, issue.4, pp.395-406, 1998. ,
DOI : 10.1007/s004010050816
In Situ Labeling of Dying Cortical Neurons in Normal Aging and in Alzheimer's Disease: Correlations with Senile Plaques and Disease Progression, Journal of Neuropathology & Experimental Neurology, vol.55, issue.11, pp.1134-1142, 1996. ,
DOI : 10.1097/00005072-199611000-00004
In Situ Immunodetection of Neuronal Caspase-3 Activation in Alzheimer Disease, Journal of Neuropathology & Experimental Neurology, vol.58, issue.9, pp.1020-1026, 1999. ,
DOI : 10.1097/00005072-199909000-00012
Quantitative assessment of cortical synaptic density in Alzheimer's disease, Neurobiology of Aging, vol.11, issue.1, pp.29-37, 1990. ,
DOI : 10.1016/0197-4580(90)90059-9
Synapse loss in the temporal lobe in Alzheimer's disease, Annals of Neurology, vol.192, issue.2, pp.190-199, 1993. ,
DOI : 10.1212/WNL.42.3.631
Alzheimer's Disease Is a Synaptic Failure, Science, vol.298, issue.5594, pp.789-791, 2002. ,
DOI : 10.1126/science.1074069
Cloning of a gene bearing missense mutations in early-onset familial
Alzheimer's disease, Nature, vol.375, issue.6534, pp.754-760, 1995. ,
DOI : 10.1038/375754a0
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene, Nature, vol.376, issue.6543, pp.775-778, 1995. ,
DOI : 10.1038/376775a0
Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I, Neurology, vol.54, issue.10, pp.2006-2008, 2000. ,
DOI : 10.1212/WNL.54.10.2006
Estimation of the Genetic Contribution of Presenilin-1 and -2 Mutations in a Population-Based Study of Presenile Alzheimer Disease, Human Molecular Genetics, vol.7, issue.1, pp.43-51, 1998. ,
DOI : 10.1093/hmg/7.1.43
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science, vol.235, issue.4791, pp.880-884, 1987. ,
DOI : 10.1126/science.2949367
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature, vol.325, issue.6106, pp.733-736, 1987. ,
DOI : 10.1038/325733a0
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease, Science, vol.235, issue.4791, pp.877-880, 1987. ,
DOI : 10.1126/science.3810169
Release of excess amyloid beta protein from a mutant amyloid beta protein precursor, Science, vol.259, issue.5094, pp.514-516, 1993. ,
DOI : 10.1126/science.8424174
Mutation of the ??-amyloid precursor protein in familial Alzheimer's disease increases ??-protein production, Nature, vol.360, issue.6405, pp.672-674, 1992. ,
DOI : 10.1038/360672a0
Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor, The Journal of biological chemistry, vol.269, pp.17741-17748, 1994. ,
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics, Science, vol.297, issue.5580, pp.353-356, 2002. ,
DOI : 10.1126/science.1072994
Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer???s Disease, Neuron, vol.85, issue.5, pp.967-981, 2015. ,
DOI : 10.1016/j.neuron.2015.02.010
Early-Versus Late-Onset Alzheimer's Disease: More than Age Alone, Journal of Alzheimer's Disease, vol.19, issue.4, pp.1401-1408, 2010. ,
DOI : 10.3233/JAD-2010-1337
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, issue.5123, pp.921-923, 1993. ,
DOI : 10.1126/science.8346443
A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease, Neuroscience Letters, vol.163, issue.2, pp.166-168, 1993. ,
DOI : 10.1016/0304-3940(93)90373-S
Apolipoprotein E genotype and Alzheimer's disease, The Lancet, vol.342, issue.8873, p.737, 1993. ,
DOI : 10.1016/0140-6736(93)91728-5
Apolipoprotein E polymorphism and Alzheimer's disease, The Lancet, vol.342, issue.8873, pp.697-699, 1993. ,
DOI : 10.1016/0140-6736(93)91705-Q
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions, Neuron, vol.11, issue.4, pp.575-580, 1993. ,
DOI : 10.1016/0896-6273(93)90070-8
ApoE and Clusterin Cooperatively Suppress A?? Levels and Deposition, Neuron, vol.41, issue.2, pp.193-202, 2004. ,
DOI : 10.1016/S0896-6273(03)00850-X
The Role of PICALM in Alzheimer???s Disease, Molecular Neurobiology, vol.7, issue.8, pp.399-413, 2015. ,
DOI : 10.1371/journal.pone.0044252
Peripheral clearance of amyloid ?? peptide by complement C3-dependent adherence to erythrocytes, Neurobiology of Aging, vol.27, issue.12, pp.1733-1739, 2006. ,
DOI : 10.1016/j.neurobiolaging.2005.09.043
Complement receptor 1 (CR1) and Alzheimer's disease, Immunobiology, vol.217, issue.2, pp.244-250, 2012. ,
DOI : 10.1016/j.imbio.2011.07.017
as Risk Factor for Alzheimer's Disease, New England Journal of Medicine, vol.368, issue.2, pp.182-184, 2013. ,
DOI : 10.1056/NEJMe1213157
Alzheimer Genetic Analysis Group, pp.117-127, 2013. ,
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database, Nature Genetics, vol.14, issue.1, pp.17-23, 2007. ,
DOI : 10.1136/bmj.315.7109.629
Estrogen and neuroprotection: from clinical observations to molecular mechanisms, Dialogues Clin Neurosci, vol.4, pp.149-161, 2002. ,
???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975. ,
DOI : 10.1016/0022-3956(75)90026-6
Cerebrospinal Fluid tau/??-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults, Archives of Neurology, vol.64, issue.3, pp.343-349, 2007. ,
DOI : 10.1001/archneur.64.3.noc60123
correlates with brain atrophy in cognitively normal elderly, Annals of Neurology, vol.5, issue.spec no 2, pp.176-183, 2009. ,
DOI : 10.1212/01.WNL.0000115115.98960.37
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease, JAMA, vol.289, pp.2094-2103, 2003. ,
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment, CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment, pp.385-393, 2009. ,
DOI : 10.1001/jama.2009.1064
Impact of amyloid imaging on drug development in Alzheimer's disease, Nuclear Medicine and Biology, vol.34, issue.7, pp.809-822, 2007. ,
DOI : 10.1016/j.nucmedbio.2007.06.015
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease, Neurology, vol.41, issue.1, pp.51-54, 1991. ,
DOI : 10.1212/WNL.41.1.51
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-746, 2007. ,
DOI : 10.1016/S1474-4422(07)70178-3
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, The Lancet Neurology, vol.13, issue.6, pp.614-629, 2014. ,
DOI : 10.1016/S1474-4422(14)70090-0
Human memory and the cholinergic system. A relationship to aging? Archives of neurology 30, pp.113-121, 1974. ,
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE, The Lancet, vol.308, issue.8000, p.1403, 1976. ,
DOI : 10.1016/S0140-6736(76)91936-X
Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions, Biological Psychiatry, vol.77, issue.8, pp.729-739, 2015. ,
DOI : 10.1016/j.biopsych.2014.10.013
Alzheimer's Disease Cooperative Study Steering CommitteeSolanezumab Study Group. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease, pp.311-321, 2014. ,
Alzheimer disease: Solanezumab???prospects for meaningful interventions in AD?, Nature Reviews Neurology, vol.6, issue.12, pp.669-670, 2015. ,
DOI : 10.1126/scitranslmed.3007941
A Plaque-Specific Antibody Clears Existing ??-amyloid Plaques in Alzheimer's Disease Mice, Neuron, vol.76, issue.5, pp.908-920, 2012. ,
DOI : 10.1016/j.neuron.2012.10.029
Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid, Proceedings of the National Academy of Sciences, vol.23, issue.33, pp.6742-6747, 2015. ,
DOI : 10.1074/jbc.M110.150565
Amyloid deposition as the central event in the aetiology of Alzheimer's disease, Trends in Pharmacological Sciences, vol.12, pp.383-388, 1991. ,
DOI : 10.1016/0165-6147(91)90609-V
The Non-Amyloidogenic Pathway: Structure and Function of ??-Secretases, Subcell. Biochem, vol.38, pp.105-127, 2005. ,
DOI : 10.1007/0-387-23226-5_5
Viral gene transfer of APPs?? rescues synaptic failure in an Alzheimer???s disease mouse model, Acta Neuropathologica, vol.29, issue.2, 2015. ,
DOI : 10.1523/JNEUROSCI.4104-09.2009
Intracellular amyloid-?? in Alzheimer's disease, Nature Reviews Neuroscience, vol.66, issue.7, pp.499-509, 2007. ,
DOI : 10.1016/S0002-9440(10)63388-3
BACE1 (??-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time, Neurobiology of Disease, vol.14, issue.1, pp.81-88, 2003. ,
DOI : 10.1016/S0969-9961(03)00104-9
Signaling effect of amyloid-??42 on the processing of A??PP, Experimental Neurology, vol.221, issue.1, pp.18-25, 2010. ,
DOI : 10.1016/j.expneurol.2009.09.002
Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity, FASEB J, vol.16, pp.1677-1679, 2002. ,
Functional activity of the novel Alzheimer's amyloid ??-peptide interacting domain (A??ID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis, Gene, vol.488, issue.1-2, pp.13-22, 2011. ,
DOI : 10.1016/j.gene.2011.06.017
The Alzheimer's Disease-Associated Amyloid ??-Protein Is an Antimicrobial Peptide, PLoS ONE, vol.5, issue.3, p.9505, 2010. ,
DOI : 10.1371/journal.pone.0009505.s002
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment, Annals of Neurology, vol.3, issue.4, pp.572-580, 1991. ,
DOI : 10.1007/978-1-4757-5876-4_29
Correlations of synaptic and pathological markers with cognition of the elderly, Neurobiology of Aging, vol.16, issue.3, pp.285-98, 1995. ,
DOI : 10.1016/0197-4580(95)00013-5
Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Annals of Neurology, vol.155, issue.6, pp.860-866, 1999. ,
DOI : 10.1016/S0002-9440(10)65184-X
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. The American journal of pathology 155, pp.853-862, 1999. ,
Soluble oligomers of the amyloid ??-protein impair synaptic plasticity and behavior, Behavioural Brain Research, vol.192, issue.1, pp.106-113, 2008. ,
DOI : 10.1016/j.bbr.2008.02.016
Correlative Memory Deficits, A?? Elevation, and Amyloid Plaques in Transgenic Mice, Science, vol.2, issue.8, pp.99-102, 1996. ,
DOI : 10.1038/nm0896-864
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles, Neuron, vol.39, issue.3, pp.409-421, 2003. ,
DOI : 10.1016/S0896-6273(03)00434-3
Intraneuronal A?? Causes the Onset of Early Alzheimer???s Disease-Related Cognitive Deficits in Transgenic Mice, Neuron, vol.45, issue.5, pp.675-688, 2005. ,
DOI : 10.1016/j.neuron.2005.01.040
Amyloid-?? protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory, Nature Medicine, vol.28, issue.8, pp.837-842, 2008. ,
DOI : 10.1111/j.1471-4159.1986.tb08501.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772133
AMPAR Removal Underlies A??-Induced Synaptic Depression and Dendritic Spine Loss, Neuron, vol.52, issue.5, pp.831-843, 2006. ,
DOI : 10.1016/j.neuron.2006.10.035
Soluble Oligomers of Amyloid ?? Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake, Neuron, vol.62, issue.6, pp.788-801, 2009. ,
DOI : 10.1016/j.neuron.2009.05.012
Progressive accumulation of amyloid-?? oligomers in Alzheimer???s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins, FEBS Journal, vol.116, issue.Pt 11, pp.3051-3067, 2010. ,
DOI : 10.1172/JCI25410
Soluble ??-Amyloid1-40 Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses, Journal of Neuroscience, vol.25, issue.48, pp.11061-11070, 2005. ,
DOI : 10.1523/JNEUROSCI.3034-05.2005
Soluble A?? Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors, Journal of Neuroscience, vol.31, issue.18, pp.6627-6638, 2011. ,
DOI : 10.1523/JNEUROSCI.0203-11.2011
Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease, Journal of Alzheimer's Disease, vol.11, issue.1, pp.97-116, 2007. ,
DOI : 10.3233/JAD-2007-11113
Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration, Journal of Alzheimer's disease : JAD, vol.33, pp.123-162, 2013. ,
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation, European Journal of Neuroscience, vol.436, issue.8, pp.1942-1950, 2005. ,
DOI : 10.1093/jnen/63.4.287
Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles, Science, vol.293, issue.5530, pp.711-714, 2001. ,
DOI : 10.1126/science.1062382
Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods? Journal of Alzheimer's disease, pp.423-429, 2008. ,
The case for rejecting the amyloid cascade hypothesis, Nature Neuroscience, vol.9, issue.6, pp.794-799, 2015. ,
DOI : 10.1016/j.cmet.2013.03.016
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014, Journal of Internal Medicine, vol.69, issue.1, pp.251-283, 2014. ,
DOI : 10.1001/archneurol.2011.233
Alzheimer-type neuropathology in transgenic mice overexpressing V717F ??-amyloid precursor protein, Nature, vol.373, issue.6514, pp.523-527, 1995. ,
DOI : 10.1038/373523a0
Formation of ??-amyloid protein deposits in brains of transgenic mice, Nature, vol.352, issue.6332, pp.239-241, 1991. ,
DOI : 10.1038/352239a0
Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice, Nature Genetics, vol.10, issue.1, pp.22-30, 1993. ,
DOI : 10.1016/0378-1119(91)90093-Q
Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice., Proceedings of the National Academy of Sciences, vol.90, issue.22, pp.10578-10582, 1993. ,
DOI : 10.1073/pnas.90.22.10578
Behavioral disturbances in transgenic mice overexpressing the V717F ??-amyloid precursor protein., Behavioral Neuroscience, vol.113, issue.5, pp.982-990, 1999. ,
DOI : 10.1037/0735-7044.113.5.982
Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice, Brain Research, vol.840, issue.1-2, pp.23-35, 1999. ,
DOI : 10.1016/S0006-8993(99)01698-4
Agedependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.21, pp.372-381, 2001. ,
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.22, pp.1858-1867, 2002. ,
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease, Proceedings of the National Academy of Sciences of the United States of America, pp.5161-5166, 2006. ,
DOI : 10.1523/JNEUROSCI.2693-05.2005
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proceedings of the National Academy of Sciences of the United States of America 94, pp.13287-13292, 1997. ,
DOI : 10.1074/jbc.271.51.32789
Pathogenic Mechanisms of Alzheimer's Disease Analyzed in the APP23 Transgenic Mouse Model, Annals of the New York Academy of Sciences, vol.395, issue.1, pp.134-139, 2000. ,
DOI : 10.1016/S0002-9440(10)65423-5
Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment, Learning & Memory, vol.13, issue.1, pp.63-71, 2006. ,
DOI : 10.1101/lm.2606
Changes in Amyloid-?? and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein, Science Translational Medicine, vol.22, issue.2, pp.194-196, 2013. ,
DOI : 10.1126/science.1194516
High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.20, pp.4050-4058, 2000. ,
Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695, Journal of Biological Chemistry, vol.20, issue.24, pp.21562-21570, 2001. ,
DOI : 10.1046/j.1471-4159.1997.69062432.x
Inflammation occurs early during the A?? deposition process in TgCRND8 mice, Neurobiology of Aging, vol.25, issue.7, pp.861-871, 2004. ,
DOI : 10.1016/j.neurobiolaging.2003.08.008
Single App knock-in mouse models of Alzheimer's disease, Nature Neuroscience, vol.97, issue.5, pp.661-663, 2014. ,
DOI : 10.1073/pnas.97.26.14731
Increased amyloid-??42(43) in brains of mice expressing mutant presenilin 1, Nature, vol.383, issue.6602, pp.710-713, 1996. ,
DOI : 10.1038/383710a0
Functional Phenotype in Transgenic Mice Expressing Mutant Human Presenilin-1, Neurobiology of Disease, vol.7, issue.2, pp.119-126, 2000. ,
DOI : 10.1006/nbdi.1999.0276
Skeletal and CNS Defects in Presenilin-1-Deficient Mice, Cell, vol.89, issue.4, pp.629-639, 1997. ,
DOI : 10.1016/S0092-8674(00)80244-5
APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout Mice, Neuron, vol.31, issue.5, pp.713-726, 2001. ,
DOI : 10.1016/S0896-6273(01)00417-2
Progressive Age-Related Impairment of the Late Long-Term Potentiation in Alzheimer's Disease Presenilin-1 Mutant Knock-in Mice, Journal of Alzheimer's Disease, vol.19, issue.3, pp.1021-1033, 2010. ,
DOI : 10.3233/JAD-2010-1302
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies, Biomolecular Engineering, vol.17, issue.6, pp.157-165, 2001. ,
DOI : 10.1016/S1389-0344(01)00067-3
Environmental Enrichment Exacerbates Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease, Journal of Neuropathology & Experimental Neurology, vol.62, issue.12, pp.1220-1227, 2003. ,
DOI : 10.1093/jnen/62.12.1220
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to ??-amyloid deposition and neurotransmitter abnormalities, Neurobiology of Disease, vol.18, issue.3, pp.602-617, 2005. ,
DOI : 10.1016/j.nbd.2004.10.022
Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation, Journal of Neuroscience, vol.26, issue.40, pp.10129-10140, 2006. ,
DOI : 10.1523/JNEUROSCI.1202-06.2006
Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model, Neurobiology of Disease, vol.33, issue.2, pp.229-235, 2009. ,
DOI : 10.1016/j.nbd.2008.10.006
Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated A??42 Accumulation in a Novel Alzheimer Transgenic Model, Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model, pp.1289-1300, 2004. ,
DOI : 10.1016/S0002-9440(10)63388-3
APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy, Acta Neuropathologica, vol.306, issue.6, pp.677-685, 2009. ,
DOI : 10.1016/S0002-9440(10)64463-X
URL : https://link.springer.com/content/pdf/10.1007%2Fs00401-009-0539-7.pdf
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein, Nat. Genet, vol.25, pp.402-405, 2000. ,
Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.22, pp.133-141, 2002. ,
The Alzheimer's A?? peptide induces neurodegeneration and apoptotic cell death in transgenic mice, Nature Genetics, vol.9, issue.1, pp.21-30, 1995. ,
DOI : 10.1083/jcb.108.2.579
A??42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice, Neuron, vol.47, issue.2, pp.191-199, 2005. ,
DOI : 10.1016/j.neuron.2005.06.030
Hippocampal Injections of Amyloid ??-Peptide 1-40 Impair Subsequent One-Trial/Day Reward Learning, Neurobiology of Learning and Memory, vol.76, issue.2, pp.125-137, 2001. ,
DOI : 10.1006/nlme.2000.3991
Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.21, pp.5703-5714, 2001. ,
Beta-Amyloid and Oxidative Stress Jointly Induce Neuronal Death, Amyloid Deposits, Gliosis, and Memory Impairment in the Rat Brain, Pharmacology, vol.76, issue.1, pp.19-33, 2006. ,
DOI : 10.1159/000088929
Progressive brain dysfunction following intracerebroventricular infusion of beta1???42-amyloid peptide, Brain Research, vol.912, issue.2, pp.128-136, 2001. ,
DOI : 10.1016/S0006-8993(01)02704-4
Effects of memantine on soluble ????25-35-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions, Neuroscience, vol.164, issue.3, pp.1199-1209, 2009. ,
DOI : 10.1016/j.neuroscience.2009.08.063
Modeling Alzheimer???s disease in transgenic rats, Molecular Neurodegeneration, vol.8, issue.1, p.37, 2013. ,
DOI : 10.1523/JNEUROSCI.4218-08.2008
Rat transgenic models with a phenotype of intracellular A?? accumulation in hippocampus and cortex, Journal of Alzheimer's Disease, vol.6, issue.3, pp.209-219, 2004. ,
DOI : 10.3233/JAD-2004-6301
Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats, Molecular medicine, vol.10, pp.36-44, 2004. ,
A transgenic rat expressing human APP with the Swedish Alzheimer???s disease mutation, Biochemical and Biophysical Research Communications, vol.358, issue.3, pp.777-782, 2007. ,
DOI : 10.1016/j.bbrc.2007.04.195
Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer???s disease, Journal of Cellular and Molecular Medicine, vol.444, issue.6b, pp.1816-1823, 2010. ,
DOI : 10.1007/978-1-59259-469-6_1
A transgenic rat model of Alzheimer's disease with extracellular A?? deposition, Neurobiology of Aging, vol.30, issue.7, pp.1078-1090, 2009. ,
DOI : 10.1016/j.neurobiolaging.2007.10.006
A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment, Neurobiology of Disease, vol.31, issue.1, pp.46-57, 2008. ,
DOI : 10.1016/j.nbd.2008.03.005
A Novel Transgenic Rat Model with a Full Alzheimer's-Like Amyloid Pathology Displays Pre-Plaque Intracellular Amyloid-??-Associated Cognitive Impairment, Journal of Alzheimer's Disease, vol.20, issue.1, pp.113-126, 2010. ,
DOI : 10.3233/JAD-2010-1349
H MRS study, Journal of Neurochemistry, vol.54, issue.4, pp.532-541, 2012. ,
DOI : 10.1016/j.neuint.2009.02.004
The grey mouse lemur: A non-human primate model for ageing studies, Ageing Research Reviews, vol.11, issue.1, pp.150-162, 2012. ,
DOI : 10.1016/j.arr.2011.07.001
URL : https://hal.archives-ouvertes.fr/hal-00650159
Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition, Neurobiology of Aging, vol.36, issue.1, pp.149-156, 2015. ,
DOI : 10.1016/j.neurobiolaging.2014.07.017
Immunohistochemical Analysis of Cerebral Cortical and Vascular Lesions in the Primate Microcebus murinus Reveal Distinct Amyloid ??1???42 and ??1???40 Immunoreactivity Profiles, Neurobiology of Disease, vol.7, issue.1, pp.1-8, 2000. ,
DOI : 10.1006/nbdi.1999.0270
Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.54, issue.2, pp.13835-13840, 2012. ,
DOI : 10.1016/0197-4580(87)90033-9
, a Natural Model of Alzheimer's Disease, Brain Pathology, vol.8, issue.Suppl. 1, pp.679-691, 2015. ,
DOI : 10.1371/journal.pone.0064019
Identifying A??-specific pathogenic mechanisms using a nematode model of Alzheimer's disease, Neurobiology of Aging, vol.36, issue.2, pp.857-866, 2015. ,
DOI : 10.1016/j.neurobiolaging.2014.10.016
ChemInform Abstract: Benzofuran-Chalcone Hybrids as Potential Multifunctional Agents Against Alzheimer???s Disease: Synthesis and in vivo Studies with Transgenic Caenorhabditis elegans., ChemInform, vol.9, issue.18, pp.2671-2684, 2014. ,
DOI : 10.1002/cmdc.201402291
Diphenyl-diselenide suppresses amyloid-?? peptide in Caenorhabditis elegans model of Alzheimer???s disease, Neuroscience, vol.278, pp.40-50, 2014. ,
DOI : 10.1016/j.neuroscience.2014.07.068
The Role of miR-124 in Drosophila Alzheimer's Disease Model by Targeting Delta in Notch Signaling Pathway, Current Molecular Medicine, vol.15, issue.10, pp.980-989, 2015. ,
DOI : 10.2174/1566524016666151123114608
Modeling the complex pathology of Alzheimer's disease in Drosophila, Experimental Neurology, vol.274, pp.58-71, 2015. ,
DOI : 10.1016/j.expneurol.2015.05.013
Linking A??42-Induced Hyperexcitability to Neurodegeneration, Learning and Motor Deficits, and a Shorter Lifespan in an Alzheimer???s Model, PLOS Genetics, vol.37, issue.3, p.1005025, 2015. ,
DOI : 10.1371/journal.pgen.1005025.s003
Cell Cultures From Animal Models of Alzheimer's Disease as a Tool for Faster Screening and Testing of Drug Efficacy, Journal of Molecular Neuroscience, vol.24, issue.1, pp.15-21, 2004. ,
DOI : 10.1385/JMN:24:1:015
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors, Cell, vol.126, issue.4, pp.663-676, 2006. ,
DOI : 10.1016/j.cell.2006.07.024
Accelerating stem cell trials for Alzheimer's disease, The Lancet Neurology, vol.15, issue.2, pp.10-1016, 2015. ,
DOI : 10.1016/S1474-4422(15)00332-4
A three-dimensional human neural cell culture model of Alzheimer???s disease, Nature, vol.5, issue.7526, pp.274-278, 2014. ,
DOI : 10.1371/journal.pone.0013947
Gene Therapy Using Adeno-Associated Virus Vectors, Clinical Microbiology Reviews, vol.21, issue.4, pp.583-593, 2008. ,
DOI : 10.1128/CMR.00008-08
URL : http://cmr.asm.org/content/21/4/583.full.pdf
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain, Nature Genetics, vol.36, issue.2, pp.148-154, 1994. ,
DOI : 10.1016/0014-4886(92)90053-S
Systemic gene delivery to the central nervous system using Adeno-associated virus, Frontiers in Molecular Neuroscience, vol.16, issue.52, p.50, 2014. ,
DOI : 10.1038/mt.2008.76
URL : https://hal.archives-ouvertes.fr/hal-01217255
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells., Proceedings of the National Academy of Sciences, vol.79, issue.6, pp.2077-2081, 1982. ,
DOI : 10.1073/pnas.79.6.2077
Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease, Molecular therapy : the journal of the American Society of Gene Therapy, pp.44-53, 2010. ,
DOI : 10.1038/mt.2009.175
CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer???s disease, Brain, vol.138, issue.8, pp.2383-2398, 2015. ,
DOI : 10.1093/brain/awv166
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal A?? levels, Molecular Neurodegeneration, vol.2, issue.1, p.11, 2007. ,
DOI : 10.1186/1750-1326-2-11
URL : http://doi.org/10.1186/1750-1326-2-11
AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice, PLoS ONE, vol.48, issue.10, p.7280, 2009. ,
DOI : 10.1371/journal.pone.0007280.s010
URL : http://doi.org/10.1371/journal.pone.0007280
Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum, PLoS ONE, vol.24, issue.3, p.59166, 2013. ,
DOI : 10.1371/journal.pone.0059166.t002
Transgenic Mice Expressing Human ??-APP751, But Not Mice Expressing ??-APP695, Display Early Alzheimer's Disease-like Histopathologya, Annals of the New York Academy of Sciences, vol.352, issue.1, pp.224-227, 1993. ,
DOI : 10.1038/352239a0
Normal cognition in transgenic BRI2-A?? mice, Molecular Neurodegeneration, vol.8, issue.1, p.15, 2013. ,
DOI : 10.1111/j.1468-2958.2002.tb00828.x
URL : http://doi.org/10.1186/1750-1326-8-15
The Ratio of Monomeric to Aggregated Forms of A??40 and A??42 Is an Important Determinant of Amyloid-?? Aggregation, Fibrillogenesis, and Toxicity, Journal of Biological Chemistry, vol.418, issue.42, pp.28176-28189, 2008. ,
DOI : 10.1073/pnas.91.25.12243
A??40 Protects Non-toxic A??42 Monomer from Aggregation, Journal of Molecular Biology, vol.369, issue.4, pp.909-916, 2007. ,
DOI : 10.1016/j.jmb.2007.04.014
??-Secretase processing of APP inhibits neuronal activity in the hippocampus, Secretase processing of APP inhibits neuronal activity in the hippocampus, pp.443-447, 2015. ,
DOI : 10.1073/pnas.1232232100
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders, Nature Reviews Neuroscience, vol.39, issue.10, pp.682-696, 2010. ,
DOI : 10.1016/S1570-9639(02)00455-7
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948541
Selective impairment of some forms of synaptic plasticity by oligomeric amyloid-? peptide in the mouse hippocampus: implication of extrasynaptic NMDA receptors, Journal of Alzheimer, vol.32, pp.183-196, 2012. ,
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders, Neuron, vol.82, issue.2, pp.279-293, 2014. ,
DOI : 10.1016/j.neuron.2014.03.030
URL : http://doi.org/10.1016/j.neuron.2014.03.030
Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats, Aging Cell, vol.12, issue.5, pp.722-735, 2010. ,
DOI : 10.1113/jphysiol.1990.sp018240
Memantine Preferentially Blocks Extrasynaptic over Synaptic NMDA Receptor Currents in Hippocampal Autapses, Journal of Neuroscience, vol.30, issue.33, pp.11246-11250, 2010. ,
DOI : 10.1523/JNEUROSCI.2488-10.2010
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932667
A? induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss, Proceedings of the National Academy of Sciences of the United States of America, pp.2518-2545, 2013. ,
DOI : 10.1073/pnas.1306832110
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704025
Activation of Extrasynaptic, But Not Synaptic, NMDA Receptors Modifies Amyloid Precursor Protein Expression Pattern and Increases Amyloid-?? Production, Journal of Neuroscience, vol.30, issue.47, pp.15927-15942, 2010. ,
DOI : 10.1523/JNEUROSCI.3021-10.2010
??-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro, Science, vol.295, issue.5556, pp.1663-1667, 2010. ,
DOI : 10.1126/science.1067389
CSP? knockout causes neurodegeneration by impairing SNAP-25 function. The EMBO journal 31, pp.829-841, 2012. ,
DOI : 10.1038/emboj.2011.467
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280561
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration, Science Translational Medicine, vol.375, issue.6531, pp.147-113, 2012. ,
DOI : 10.1038/375488a0
Mutant presenilins specifically elevate the levels of the 42 residue ??-amyloid peptide in vivo: evidence for augmentation of a 42-specific ?? secretase, Human Molecular Genetics, vol.13, issue.2, pp.159-170, 2004. ,
DOI : 10.1093/hmg/ddh019
Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer???s disease, Acta Neuropathologica Communications, vol.164, issue.1, p.17, 2014. ,
DOI : 10.1016/j.neuroscience.2009.09.024
Aftins increase amyloid-?42, lower amyloid-?38, and do not alter amyloid-?40 extracellular production in vitro: toward a chemical model of Alzheimer's disease? Journal of Alzheimer's disease, pp.107-120, 2013. ,
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice, The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.20, pp.3606-3611, 2000. ,
Alzheimer's disease and cognition: an old story coming of age? Progress in neurobiology 89, pp.153-161, 2009. ,
Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice, Neurobiology of Aging, vol.36, issue.2, pp.1013-1028, 2015. ,
DOI : 10.1016/j.neurobiolaging.2014.10.033